Updated:
RenalGuard
RenalGuard is a Menlo Park-based single-family office investing in digital health and healthcare services startups across Europe and North America.
RenalGuard
RenalGuard operates as a single-family office in Menlo Park, California, concentrating on venture-stage investments in healthcare. Founded by a healthcare-focused family, the firm directs resources toward startups that develop digital health tools and healthcare services — a niche that aligns capital with clinical need. The firm's strategy spans early-stage equity in digital health, healthcare services, and related technology platforms. RenalGuard backs startups across Europe and North America, targeting companies where its capital and operational context can support growth. Portfolio examples include health-tech ventures that bridge clinical workflows and patient outcomes, though specific named holdings are not publicly detailed. Team size and additional office locations are not publicly disclosed. RenalGuard maintains a lean operational footprint, with no known philanthropic vehicles or operating companies attached. As of mid-2026, no recent public transactions or news events have surfaced for the firm, suggesting a private posture by design. A structural differentiator is the firm's stated geographic dual-focus on Europe and North America, rare for a US-based single-family office of modest profile. This transatlantic lens may stem from family ties or investment opportunities in both regions, though the underlying architecture remains opaque due to limited public disclosure.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Sector focus
Frequently asked questions
What investment stages does RenalGuard target?
RenalGuard focuses on early-stage startups in digital health and healthcare services. The firm's deployment is equity-based, backing companies at the venture stage where capital can drive clinical and technological development.
Does RenalGuard invest only in healthcare?
The firm's known sector focus is digital health and healthcare services, per public record. There is no evidence of investments outside of healthcare verticals.
How does RenalGuard source deal flow?
Deal sourcing details are not publicly disclosed. As a family office operating in specialized healthcare niches, the firm likely leverages professional networks and industry relationships to identify opportunities.
Is RenalGuard open to co-investments with external partners?
RenalGuard's posture on co-investments is not publicly known. The firm does not appear to market co-investment opportunities broadly.
What geographies does RenalGuard cover?
The firm invests in Europe and North America, per public record. This dual-continent focus distinguishes it from many US-based single-family offices.
Who runs investment decisions at RenalGuard?
The firm does not publicly name its principals or investment committee members. Decision-making structure is opaque due to limited disclosure.
What is the origin of RenalGuard's wealth?
The wealth origin is not publicly disclosed. The firm's name may suggest a healthcare-related background, but no specific family or industry origin is confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: